Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Huijgens, PC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 91 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Uyl-de Groot, CA; Hartog, JGD; Huijgens, PC; Willemze, R; Van Ineveld, BM
      Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Netelenbos, T; Drager, AM; van het Hof, B; Kessler, FL; Delouis, C; Huijgens, PC; van den Born, J; van Dijk, W
      Differences in sulfation patterns of heparan sulfate derived from human bone marrow and umbilical vein endothelial cells

      EXPERIMENTAL HEMATOLOGY
    3. de Kreuk, AM; Jonkhoff, AR; Zevenbergen, Z; Hendriks, ECM; Schuurhuis, GJ; Ossenkoppele, GJ; Drager, AM; van Oostveen, JW; Huijgens, PC
      Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days

      BONE MARROW TRANSPLANTATION
    4. Huijgens, PC; Dekker-van Roessel, HM; Jonkhoff, AR; Admiraal, GC; Zweegman, S; Schuurhuis, GJ; Ossenkoppele, GJ
      High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem cell transplantation in multiple myeloma

      BONE MARROW TRANSPLANTATION
    5. van der Meer, PF; Pietersz, RNI; Tiekstra, M; Huijgens, PC; Dekker, WJA; Reesink, HW
      WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures

      TRANSFUSION
    6. Zweegman, S; Veenhof, MA; Huijgens, PC; Schuurhuis, GJ; Drager, AM
      Regulation of megakaryocytopoiesis in an in vitro stroma model: Preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation

      EXPERIMENTAL HEMATOLOGY
    7. Timmers, GJ; Zweegman, S; Simoons-Smit, AM; van Loenen, AC; Touw, D; Huijgens, PC
      Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

      BONE MARROW TRANSPLANTATION
    8. Colnot, DR; Quak, JJ; Roos, JC; van Lingen, A; Wilhelm, AJ; van Kamp, GJ; Huijgens, PC; Snow, GB; van Dongen, GAMS
      Phase I therapy study of Re-186-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck

      JOURNAL OF NUCLEAR MEDICINE
    9. de Boer, F; Drager, AM; Van Haperen, MJAM; van der Wall, E; Kessler, F; Huijgens, PC; Pinedo, HM; Schuurhuis, GJ
      The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens

      BRITISH JOURNAL OF HAEMATOLOGY
    10. Huijgens, PC; Timmers, GJ; Simoons-Smit, AM; Van Loenen, AC
      Itraconazole versus fluconazole in neutropenic patients

      BRITISH JOURNAL OF HAEMATOLOGY
    11. Uyl-De Groot, CA; Ossenkoppele, GJ; Buijt, I; Huijgens, PC
      Stem cell transplantations in patients with malignant lymphoma: Costs in aDutch university hospital in the period 1984-1995

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Timmers, GJ; Falke, THM; Rauwerda, JA; Huijgens, PC
      Deep vein thrombosis as a presenting symptom of congenital interruption ofthe inferior vena cava

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    13. Uyl-de Groot, CA; Ossenkoppele, GJ; Buijt, I; Huijgens, PC
      Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma

      PHARMACOECONOMICS
    14. Leijdekkers, VJ; Vahl, AC; Leenders, JJM; Huijgens, PC; Gans, ROB; Rauwerda, JA
      Risk factors for premature atherosclerosis

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    15. Zweegman, S; Veenhof, MA; Debili, N; Schuurhuis, GJ; Huijgens, PC; Drager, AM
      Megakaryocytic differentiation of human progenitor cells is negatively influenced by direct contact with stroma

      LEUKEMIA
    16. Drager, AM; van der Hem, KG; Zevenbergen, A; Odding, JH; Huijgens, PC; Schuurhuis, GJ
      Role of TNF alpha in bryostatin-induced inhibition of human hematopoiesis

      LEUKEMIA
    17. Vellenga, E; van Putten, WLJ; Boogaerts, MA; Daenen, SMGJ; Verhoef, GEG; Hagenbeek, A; Jonkhoff, AR; Huijgens, PC; Verdonck, LF; van der Lelie, J; Schouten, HC; Gmur, J; Wijermans, P; Gratwohl, A; Hess, U; Fey, MF; Lowenberg, B
      Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?

      BONE MARROW TRANSPLANTATION
    18. Coumans, ABC; Huijgens, PC; Jakobs, C; Schats, R; de Vries, JIP; van Pampus, MG; Dekker, GA
      Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion

      HUMAN REPRODUCTION
    19. Huijgens, PC; Simoons-Smit, AM; van Loenen, AC; Prooy, E; van Tinteren, H; Ossenkoppele, GJ; Jonkhoff, AR
      Fluconazole versus itraconazole for the prevention of fungal infections inhaemato-oncology

      JOURNAL OF CLINICAL PATHOLOGY
    20. van Pampus, MG; Dekker, GA; Wolf, H; Huijgens, PC; Koopman, MMW; von Blomberg, BME; Buller, HR
      High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    21. Van Leeuwen-Stok, EA; Jonkhoff, AR; Visser-Platier, AWJ; Drager, AM; Teule, GJJ; Huijgens, PC; Schuurhuis, GJ
      Cell cycle dependency of (67)gallium uptake and cytotoxicity in human celllines of hematological malignancies

      LEUKEMIA & LYMPHOMA
    22. Buijt, I; Ossenkoppele, GJ; Uyl-de Groot, CA; Huijgens, PC
      Costs of intensive treatment and follow-up of patients with multiple myeloma

      ANTI-CANCER DRUGS
    23. RIYAZI N; LEEDA M; DEVRIES JIP; HUIJGENS PC; VANGEIJN HP; DEKKER GA
      LOW-MOLECULAR-WEIGHT HEPARIN COMBINED WITH ASPIRIN IN PREGNANT-WOMEN WITH THROMBOPHILIA AND A HISTORY OF PREECLAMPSIA OR FETAL GROWTH RESTRICTION - A PRELIMINARY-STUDY

      European journal of obstetrics, gynecology, and reproductive biology
    24. ADMIRAAL GC; DEKREUK AM; JONKHOFF AR; GLOUDEMANS IJM; SCHUURHUIS GJ; OSSENKOPPELE GJ; HUIJGENS PC
      HIGH-DOSE MELPHALAN (HDM) AND G-CSF STIMULATED WHOLE-BLOOD RESCUE FOLLOWED BY BUSULPHAN CYCLOPHOSPHAMIDE (BU/CY) AND AUTOLOGOUS PERIPHERAL-BLOOD (PB) OR BONE-MARROW STEM-CELL (BM) TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)/

      Bone marrow transplantation
    25. SCHOORDIJK MCE; JONKHOFF AR; RUEL PC; OSSENKOPPELE GJ; HUIJGENS PC
      THERAPEUTIC LEUKAPHERESIS WITH THE BAXTER CS 3000(R) IN A PATIENT WITH ALL

      Bone marrow transplantation
    26. DRAGER AM; OSSENKOPPELE GJ; JONKHOFF AR; SCHUURHUIS GJ; HUIJGENS PC
      NEW STRATEGIES IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION - G-CSF-MOBILIZED UNPROCESSED WHOLE-BLOOD

      Brazilian journal of medical and biological research
    27. HUIJGENS PC; SIMOONSSMIT AM; VANLOENEN AC; PROOY E; OSSENKOPPELE GJ; JONKHOFF AR
      FLUCONAZOLE VERSUS INTRACONAZOLE FOR THE PREVENTION OF FUNGAL-INFECTIONS IN HEMATOONCOLOGY

      British Journal of Haematology
    28. ZIJLSTRA JM; MENS JW; SLOTMAN BJ; SNEEUW KCA; JONKHOFF AR; HUIJGENS PC
      RADIOTHERAPY IN EARLY-STAGE HODGKINS-DISEASE, LONG-TERM RESULTS AND SIDE-EFFECTS

      British Journal of Haematology
    29. ZWEEGMAN S; VEENHOF MA; HUIJGENS PC; SCHUURHUIS GJ; DRAGER AM
      MEGAKARYOCYTIC DIFFERENTIATION OF HUMAN PROGENITOR CELLS - THE INFLUENCE OF ADHESION OF STROMA

      British Journal of Haematology
    30. NETELENBOS T; VANDIJK W; METHORST DQ; VANHETHOF BJ; VANHAPEREN MJAM; HUIJGENS PC; DRAGER AM
      PROTEOGLYCAN-DEPENDENT HEMATOPOIETIC PROGENITOR CELLS AND BONE-MARROWENDOTHELIAL-CELLS

      British Journal of Haematology
    31. RAEMAEKERS J; VANTVEER M; VERHOEF G; HUIJGENS PC; SONNEVELD P; DEBOCK B
      FAVORABLE LONG-TERM RESULTS OF A 2-HOURS INFUSION REGIMEN OF 2-CHLORODEOXYADENOSINE IN HAIRY-CELL LEUKEMIA

      British Journal of Haematology
    32. VAHL AC; MACKAAY AJC; HUIJGENS PC; SCHEFFER GJ; RAUWERDA JA
      HEMOSTASIS DURING INFRARENAL AORTIC-ANEURYSM SURGERY - EFFECT OF VOLUME LOADING AND CROSS-CLAMPING

      European journal of vascular and endovascular surgery
    33. WIJERMANS PW; KRULDER JWM; HUIJGENS PC; NEVE P
      CONTINUOUS-INFUSION OF LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE IN ELDERLY PATIENTS WITH HIGHRISK MYELODYSPLASTIC SYNDROME

      Leukemia
    34. WIJERMANS PW; KRULDER JWM; HUIJGENS PC; NEVE P
      CONTINUOUS-INFUSION OF LOW-DOSE 5-AZA-2'-DEOXYCYTIDINE IN ELDERLY PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROME

      Leukemia
    35. DEKKER AW; VANTVEER MB; SIZOO W; HAAK HL; VANDERLELIE J; OSSENKOPPELE G; HUIJGENS PC; SCHOUTEN HC; SONNEVELD P; WILLEMZE R; VERDONCK LF; VANPUTTEN WLJ; LOWENBERG B
      INTENSIVE POSTREMISSION CHEMOTHERAPY WITHOUT MAINTENANCE THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA

      Journal of clinical oncology
    36. LOWENBERG B; BOOGAERTS MA; DAENEN SMGJ; VERHOEF GEG; HAGENBEEK A; VELLENGA E; OSSENKOPPELE GJ; HUIJGENS PC; VERDONCK LF; VANDERLELIE J; WIELENGA JJ; SCHOUTEN HC; GMUR J; GRATWOHL A; HESS U; FEY MF; VANPUTTEN WLJ
      VALUE OF DIFFERENT MODALITIES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR APPLIED DURING OR AFTER INDUCTION THERAPY OF ACUTE MYELOID-LEUKEMIA

      Journal of clinical oncology
    37. DEVRIES JIP; DEKKER GA; HUIJGENS PC; JAKOBS C; BLOMBERG BME; VANGEIJN HP
      HYPERHOMOCYSTEINAEMIA AND PROTEIN-S DEFICIENCY IN COMPLICATED PREGNANCIES

      British journal of obstetrics and gynaecology
    38. ZWEEGMAN S; VEENHOF MA; HUIJGENS PC; DRAGER AM
      THE INFLUENCE OF ADHESION TO STROMA ON MEGAKARYOCYTIC DIFFERENTIATIONOF HUMAN PROGENITOR CELLS

      Blood
    39. VERVLOET MG; HUIJGENS PC; OSSENKOPPELE GJ
      SAFETY AND EFFICACY OF CEFPIROME AS EMPIRICAL THERAPY IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND FEVER

      Blood
    40. GROOT CAL; HUIJGENS PC; RUTTEN FFH
      COLONY-STIMULATING FACTORS AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - BENEFITS AND COSTS

      PharmacoEconomics
    41. TERWEE PM; MAHESH S; AUFENACKER THJ; HUIJGENS PC; GANS ROB
      AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION - RISK FOR DEVELOPMENT OF RENAL-FAILURE

      Journal of the American Society of Nephrology
    42. OSSENKOPPELE GJ; SCHUURHUIS GJ; JONKHOFF AR; VANDERHEM KG; LEGDEUR MCJC; BOOTBAKKER A; WESTRA AH; DRAGER AM; HUIJGENS PC
      HIGH-DOSE MELPHALAN WITH RE-INFUSION OF UNPROCESSED, G-CSF-PRIMED WHOLE-BLOOD IS EFFECTIVE AND NONTOXIC THERAPY IN MULTIPLE-MYELOMA

      European journal of cancer
    43. WOLVIUS EB; VANDERVALK P; VANDERWAL JE; VANDIEST PJ; HUIJGENS PC; VANDERWAAL I; SNOW GB
      PRIMARY NON-HODGINS LYMPHOMA OF THE SALIVARY-GLANDS - AN ANALYSIS OF 22 CASES

      Journal of oral pathology & medicine
    44. VANLEEUWENSTOK AE; SCHUURHUIS GJ; DRAGER AM; VISSERPLATIER AWJ; VANDIEREN EB; TEULE GJJ; HUIJGENS PC
      RADIOTOXIC EFFECT AND DOSIMETRY OF GA-67 IN MULTICELLULAR SPHEROIDS AS COMPARED TO SINGLE CELLS OF THE LYMPHOMA CELL-LINE U715

      International journal of radiation oncology, biology, physics
    45. JANSSEN JJWM; VANSCHIJNDEL RJMS; CLEMENT EHV; OSSENKOPPELE GJ; THIJS LG; HUIJGENS PC
      OUTCOME OF ICU TREATMENT IN INVASIVE ASPERGILLOSIS

      Intensive care medicine
    46. OSSENKOPPELE GJ; SCHUURHUIS GJ; JONKHOFF AR; DRAGER AM; WESTRA G; OBERINK JW; LEGDEUR MCJC; DEKREUK AM; ZWEEGMAN S; HUIJGENS PC
      G-CSF (FILGRASTIM)-STIMULATED WHOLE-BLOOD KEPT UNPROCESSED AT 4-DEGREES-C DOES SUPPORT A BEAM-LIKE REGIMEN IN BAD-RISK LYMPHOMA

      Bone marrow transplantation
    47. DEKREUK AM; OSSENKOPPELE GJ; MEIJER CJLM; HUIJGENS PC
      PROGNOSTIC FACTORS FOR SURVIVAL OF NON-HODGKINS-LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    48. KIBURG B; MOORERVANDELFT CM; HEIMANS JJ; HUIJGENS PC; BOER HH
      IN-VIVO MODULATION OF VINCRISTINE-INDUCED NEUROTOXICITY IN LYMNAEA-STAGNALIS, BY THE ACTH(4-9) ANALOG ORG-2766

      Journal of neuro-oncology
    49. VANDERHEM KG; SCHUURHUIS GJ; DRAGER AM; ODDING JH; HUIJGENS PC
      HETEROGENOUS EFFECTS OF BRYOSTATIN ON HUMAN MYELOID-LEUKEMIA CLONOGENICITY - DOSE AND TIME SCHEDULING DEPENDENCY

      Leukemia research
    50. JANSSEN MJFM; DEEGENS JK; KAPINGA TH; BEUKHOF JR; HUIJGENS PC; VANLOENEN AC; VANDERMEULEN J
      CITRATE COMPARED TO LOW-MOLECULAR-WEIGHT HEPARIN ANTICOAGULATION IN CHRONIC-HEMODIALYSIS PATIENTS

      Kidney international
    51. VANLEEUWENSTOK AE; SCHUURHUIS GJ; DRAGER AM; VISSERPLATIER AWJ; TEULE GJJ; HUIJGENS PC
      EFFECT OF MODULATION OF THE TRANSFERRIN RECEPTOR ON GA-67 UPTAKE AND CYTOTOXICITY IN LYMPHOMA CELL-LINES

      British Journal of Cancer
    52. HUIJGENS PC; OSSENKOPPELE GJ; JONKHOFF AR; LEGDEUR MCJC; ZWEEGMAN S; GLOUDEMANS IJM
      HIGH-DOSE MELPHALAN FOLLOWED BY BUSULFAN-CYCLOFOSFAMIDE AND STEM-CELLRESCUE IN MULTIPLE-MYELOMA

      Blood
    53. VANOOSTVEEN JW; THIJSEN SET; BOCXEMAAT C; TOL C; HUIJGENS PC
      FACTOR-V LEIDEN IDENTIFIED BY A FUNCTIONAL APC ACTIVITY TEST AND PCR MEDIATED MUTATION DETECTION IN PATIENTS WITH VENOUS THROMBOSIS

      Blood
    54. GROOT CAUD; OKHUIJSEN SY; HAGENBEEK A; HUIJGENS PC; VANIMHOFF GW; LOWENBERG B; VERDONCK LF; RUTTEN FFH
      COSTS OF INTRODUCING AUTOLOGOUS BMT IN THE TREATMENT OF LYMPHOMA AND ACUTE-LEUKEMIA IN THE NETHERLANDS

      Bone marrow transplantation
    55. VANDERHEM KG; DRAGER AM; ODDING JH; HUIJGENS PC
      EFFECTS OF BRYOSTATIN-5 AND HEMATOPOIETIC GROWTH-FACTORS ON ACUTE MYELOID-LEUKEMIA CELL-DIFFERENTIATION, PROLIFERATION, AND PRIMARY PLATINGEFFICIENCY

      Leukemia research
    56. JONKHOFF AR; HUIJGENS PC; VERSTEEGH RT; VANLINGEN A; OSSENKOPPELE GJ; DRAGER AM; TEULE GJJ
      RADIOTOXICITY OF 67-GALLIUM ON MYELOID LEUKEMIC BLASTS

      Leukemia research
    57. VANDERHEM KG; DRAGER AM; ODDING JH; LANGENHUIJSEN MMAC; HUIJGENS PC
      BRYOSTATIN-5 STIMULATES NORMAL HUMAN HEMATOPOIESIS AND INHIBITS PROLIFERATION OF HL-60 LEUKEMIC-CELLS

      Leukemia research
    58. MULLER EW; DEWOLF JTM; EGGER R; WIJERMANS PW; HUIJGENS PC; HALIE MR; VELLENGA E
      LONG-TERM TREATMENT WITH INTERFERON-ALPHA-2B FOR SEVERE PRURITUS IN PATIENTS WITH POLYCYTHEMIA-VERA

      British Journal of Haematology
    59. JONKHOFF AR; PLAIZIER MABD; OSSENKOPPELE GJ; TEULE GJJ; HUIJGENS PC
      HIGH-DOSE GA-67 THERAPY IN PATIENTS WITH RELAPSED ACUTE-LEUKEMIA - A FEASIBILITY STUDY

      British Journal of Cancer
    60. DEKKER GA; DEVRIES JIP; DOELITZSCH PM; HUIJGENS PC; VONBLOMBERG BME; JAKOBS C; VANGEIJN HP
      UNDERLYING DISORDERS ASSOCIATED WITH SEVERE EARLY-ONSET PREECLAMPSIA

      American journal of obstetrics and gynecology
    61. WOLVIUS EB; VANDERVALK P; VANDERWAL JE; VANDIEST PJ; HUIJGENS PC; VANDERWAAL I; SNOW GB
      PRIMARY EXTRANODAL NON-HODGKIN-LYMPHOMA OF THE ORAL CAVITY - AN ANALYSIS OF 34 CASES

      European journal of cancer. Part B, Oral oncology
    62. VANDELOOSDRECHT AA; OSSENKOPPELE GJ; BEELEN RHJ; BROEKHOVEN MG; VANHOOFF MHA; DRAGER AM; HUIJGENS PC; LANGENHUIJSEN MMAC
      MATURATION-DEPENDENT SUSCEPTIBILITY TO MONOCYTE-MEDIATED CYTOTOXICITYIN ACUTE MYELOID-LEUKEMIA

      Leukemia
    63. VANDERHEM KG; DRAGER AM; HUIJGENS PC; TOL C; DEVILLE W; LANGENHUIJSEN MMAC
      THE DIFFERENTIATION-INDUCING EFFECT OF BRYOSTATIN-5 ON HUMAN MYELOID BLAST CELLS IS POTENTIATED BY VITAMIN-D-3

      Leukemia
    64. DAENEN S; LOWENBERG B; SONNEVELD P; VANPUTTEN WLJ; VERHOEF G; VANVELDHOVEN M; HUIJGENS PC
      EFFICACY OF ETOPOSIDE AND MITOXANTRONE IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA REFRACTORY TO STANDARD INDUCTION THERAPY AND INTERMEDIATE-DOSE CYTARABINE WITH AMSIDINE

      Leukemia
    65. TAPHOORN MJB; SCHIPHORST AK; SNOEK FJ; LINDEBOOM J; WOLBERS JG; KARIM ABMF; HUIJGENS PC; HEIMANS JJ
      COGNITIVE FUNCTIONS AND QUALITY-OF-LIFE IN PATIENTS WITH LOW-GRADE GLIOMAS - THE IMPACT OF RADIOTHERAPY

      Annals of neurology
    66. VANDIEREN EB; VANLINGEN A; ROOS JC; HUIJGENS PC; BARENDSEN GW; TEULE GJJ
      A DOSIMETRIC MODEL FOR INTRATHECAL TREATMENT WITH I-131 AND (67)GA

      International journal of radiation oncology, biology, physics
    67. JONKHOFF AR; VONDIEREN EB; HUIJGENS PC; VERSTEEGH RT; DRAGER A; VANDERLOOSDRECHT AA; TEULE GJJ
      BIOLOGICAL EFFECTIVENESS OF 67-GALLIUM DECAY IN HL-60 CELLS COMPARED WITH EXTERNAL LOW-DOSE RATE GAMMA-IRRADIATION - EFFECTS ON PROLIFERATION, G2 ARREST, AND CLONOGENIC CAPACITY

      International journal of radiation oncology, biology, physics
    68. OSSENKOPPELE GJ; JONKHOFF AR; HUIJGENS PC; NAUTA JJP; VANDERHEM KG; DRAGER AM; LANGENHUIJSEN MMAC
      PERIPHERAL-BLOOD PROGENITORS MOBILIZED BY G-CSF (FILGRASTIM) AND REINFUSED AS UNPROCESSED AUTOLOGOUS WHOLE-BLOOD SHORTEN THE PANCYTOPENIC PERIOD FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA

      Bone marrow transplantation
    69. JANSSEN MJFM; HUIJGENS PC; BOUMAN AA; OE PL; VANDERMEULEN J
      CITRATE ANTICOAGULATION AND DIVALENT-CATIONS IN HEMODIALYSIS

      Blood purification
    70. VANPAMPUS ECM; HUIJGENS PC; ZEVENBERGEN A; VERHEUGT FWA; LANGENHUIJSEN MMAC
      CIRCULATING HUMAN MEGAKARYOCYTES IN CARDIAC DISEASES

      European journal of clinical investigation
    71. VERHEUGT FWA; VANPAMPUS ECM; HUIJGENS PC; LANGENHUIJSEN MMAC
      CIRCULATING MEGAKARYOCYTES IN PATIENTS WITH UNSTABLE ANGINA AND ACUTEMYOCARDIAL-INFARCTION - NUMBER, PLOIDY DISTRIBUTION AND BETA-1-INTEGRIN ADHESION ANTIGENS

      Circulation
    72. VERHEUGT FWA; VANPAMPUS ECM; HUIJGENS PC; LANGENHUIJSEN MMAC
      CIRCULATING MEGAKARYOCYTES IN PATIENTS WITH UNSTABLE ANGINA AND ACUTEMYOCARDIAL-INFARCTION - NUMBER, PLOIDY DISTRIBUTION AND BETA-1-INTEGRIN ADHESION ANTIGENS

      Circulation
    73. KIBURG B; VANDELOOSDRECHT AA; SCHWEITZER KM; OSSENKOPPELE GJ; MULLER LJ; HEIMANS JJ; HUIJGENS PC
      EFFECTS OF THE ACTH(4-9) ANALOG, ORG-2766, ON VINCRISTINE CYTOTOXICITY IN 2 HUMAN LYMPHOMA CELL-LINES, U937 AND U715

      British Journal of Cancer
    74. OSSENKOPPELE GJ; JONKHOFF AR; VANDERHEM KG; LEGDEUR MCJC; SCHUURHUIS GJ; DRAGER AM; HUIJGENS PC
      UNPROCESSED WHOLE-BLOOD OBTAINED AFTER G-CSF PRIMING HASTENS HEMATOLOGIC RECOVERY IN PATIENTS WITH LYMPHOID MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY

      Blood
    75. VANLEEUWENSTOK AE; DRAGER AM; SCHUURHUIS GJ; PLATIER AWJ; TEULE GJJ; HUIJGENS PC
      GA-67 IN THE HUMAN LYMPHOID-CELL LINE U-715 - UPTAKE, CYTOTOXICITY AND INTRACELLULAR-LOCALIZATION

      International journal of radiation biology
    76. JANSSEN MJFM; HUIJGENS PC; BOUMAN AA; OE PL; DONKER AJM; VANDERMEULEN J
      CITRATE VERSUS HEPARIN ANTICOAGULATION IN CHRONIC-HEMODIALYSIS PATIENTS

      Nephrology, dialysis, transplantation
    77. HUIJGENS PC; JONKHOFF AR; HOEKSTRA OS; OSSENKOPPELE GJ; TEULE GJJ
      THERAPEUTIC POTENTIAL OF INTRAVENOUS 67-GALLIUM IN NON-HODGKINS-LYMPHOMA

      European journal of haematology
    78. VANPAMPUS ECM; HUIJGENS PC; ZEVENBERGEN A; TWAALFHOVEN H; VANKAMP GJ; LANGENHUIJSEN MMAC
      INFLUENCE OF ASPIRIN ON HUMAN MEGAKARYOCYTE PROSTAGLANDIN SYNTHESIS

      European journal of haematology
    79. VANPAMPUS ECM; HUIJGENS PC; VERHEUGT FWA; LANGENHUIJSEN MMAC
      CHARACTERISTICS OF CIRCULATING MEGAKARYOCYTES IN PATIENTS WITH UNSTABLE ANGINA AND ACUTE MYOCARDIAL-INFARCTION

      Experimental hematology
    80. VANDERHEM KG; DRAGER AM; HUIJGENS PC; LANGENHUIJSEN MMAC
      BRYOSTATIN-5 INDUCES LEUKEMIC-CELL DIFFERENTIATION

      Experimental hematology
    81. VANLEEUWENSTOK AE; DRAGER AM; PLATIER AWJ; TEULE GJJ; HUIJGENS PC
      INTRACELLULAR-LOCALIZATION AND MECHANISM OF CYTOTOXICITY OF (57)GALLIUM IN THE HUMAN LYMPHOMA CELL-LINE U-715

      Experimental hematology
    82. JONKHOFF AR; HUIJGENS PC; VANDIEREN EB; VERSTEEGH RT; DRAGER AM; TEULE GJJ
      BIOLOGICAL EFFECTIVENESS OF 67-GALLIUM IN HL-60 CELLS COMPARED WITH EXTERNAL LOW-DOSE RATE GAMMA-IRRADIATION

      Experimental hematology
    83. OSSENKOPPELE GJ; JONKHOFF AR; HUIJGENS PC; VANDERHEM KG; DRAGER AM; LANGENHUIJSEN MMAC
      PERIPHERAL STEM-CELLS MOBILIZED BY G-CSF AND REINFUSED AS UNPROCESSEDAUTOLOGOUS WHOLE-BLOOD HASTEN BONE-MARROW RECOVERY FOLLOWING HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA

      Experimental hematology
    84. SCHWEITZER CM; VANDELOOSDRECHT AA; JONKHOFF AR; OSSENKOPPELE GJ; HUIJGENS PC; DRAGER AM; BROEKHOVEN MG; LANGENHUIJSEN MMAC
      SPECTROPHOTOMETRIC DETERMINATION OF CLONOGENIC CAPACITY OF LEUKEMIC-CELLS IN A SEMISOLID MICROTITER CULTURE SYSTEM

      Experimental hematology
    85. BOOMGAARD MN; STULP JG; DEKORTE D; PIETERSZ RNI; REESINK HW; HUIJGENS PC; LOOS JA
      EFFECT OF PREINCUBATION AT 37-DEGREES-C OF PLATELET CONCENTRATES ON THE POSTTRANSFUSION PLATELET-ADHESION CAPACITY TO COLLAGEN AND FIBRINOGEN

      Haemostasis
    86. VANDERWIEL HE; LIPS P; HUIJGENS PC; NETELENBOS JC
      EFFECTS OF SHORT-TERM LOW-DOSE HEPARIN ADMINISTRATION ON BIOCHEMICAL PARAMETERS OF BONE TURNOVER

      Bone and mineral
    87. JONKHOFF AR; HUIJGENS PC; SCHREUDER WO; TEULE GJJ; HEIMANS JJ
      HYPOPHYSEAL NON-HODGKINS-LYMPHOMA PRESENTING WITH CLINICAL PANHYPOPITUITARISM SUCCESSFULLY TREATED WITH CHEMOTHERAPY

      Journal of neuro-oncology
    88. HOEKSTRA OS; OSSENKOPPELE GJ; GOLDING R; VANLINGEN A; VISSER GWM; TEULE GJJ; HUIJGENS PC
      EARLY TREATMENT RESPONSE IN MALIGNANT-LYMPHOMA, AS DETERMINED BY PLANAR FLUORINE-18-FLUORODEOXYGLUCOSE SCINTIGRAPHY

      The Journal of nuclear medicine
    89. OSSENKOPPELE GJ; JONKHOFF AR; HUIJGENS PC; VANDERHEM KG; DRAGER AM; LANGENHUIJSEN MMAC
      REINFUSION OF UNPROCESSED WHOLE-BLOOD AFTER G-CSF INDUCED STEM-CELL MOBILIZATION SHORTENS THE PANCYTOPENIC PERIOD AFTER HIGH-DOSE MELPHALAN

      Blood
    90. VANDERHEM KG; DRAGER AM; HUIJGENS PC; ODDING JH; LANGENHUIJSEN MMAC
      EFFECT OF BRYOSTATIN-5 ON NORMAL AND LEUKEMIC CLONOGENIC CAPACITY

      Blood
    91. VANDELOOSDRECHT AA; OSSENKOPPELE GJ; BEELEN RHJ; BROEKHOVEN MG; VANHOOFF MHA; DRAGER AM; HUIJGENS PC; LANGENHUIJSEN MMAC
      MONOCYTE MEDIATED CYTOTOXICITY IN ACUTE MYELOID-LEUKEMIA IS RELATED TO FAB-CLASSIFICATION AND IMMUNOPHENOTYPE OF LEUKEMIC-CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 14:13:24